TQVAX Performance — T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund, Advisor Class
Data updated: 2026-08-27
TQVAX returned +14.36% year to date and +25.41% over one year to Jun 2026. Annualised returns are +17.62% over 3 years and +11.56% over 5 years. The fund beat its US Large Value category average: $100 invested three years ago grew to $163, against $158 for the category, and to $125 over one year, against $121. Volatility over the past three years was 12.31% a year. In the 12 months to Jun 2026 the fund took in a net $3.4M, and assets reached $82.90M.
TQVAX Growth of $100
What $100 invested in T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | TQVAX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $125 | $121 |
| 3 years (Jul 2023 – Jun 2026) | $163 | $158 |
| 5 years (Jul 2021 – Jun 2026) | $173 | $165 |
| Since data start (Jul 2019 – Jun 2026) | $228 | $223 |
TQVAX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +14.36% |
| 1 year | +25.41% |
| 3 years (annualised) | +17.62% |
| 5 years (annualised) | +11.56% |
TQVAX Annual Returns
Calendar-year total returns of T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +14.36% |
| 2025 | +14.34% |
| 2024 | +15.75% |
| 2023 | +11.43% |
| 2022 | −3.65% |
| 2021 | +28.44% |
| 2020 | −0.64% |
| 2019 (Jul–Dec) | +10.05% |
TQVAX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.6% | +3.1% | −5.2% | +8.1% | +2.6% | +1.8% | — | — | — | — | — | — |
| 2025 | +4.7% | +0.4% | −2.5% | −3.6% | +2.6% | +2.9% | +0.8% | +3.7% | +1.4% | +0.4% | +2.0% | +1.0% |
| 2024 | +1.5% | +3.7% | +6.0% | −3.8% | +2.8% | −1.2% | +5.2% | +2.0% | +0.7% | −0.4% | +6.2% | −7.2% |
| 2023 | +4.9% | −2.9% | −2.1% | +2.2% | −4.7% | +6.9% | +3.7% | −2.5% | −2.5% | −3.1% | +7.3% | +4.9% |
| 2022 | +0.2% | −0.6% | +1.8% | −4.6% | +3.1% | −9.5% | +5.2% | −2.4% | −8.9% | +12.4% | +5.6% | −4.0% |
| 2021 | 0.0% | +7.7% | +7.2% | +3.4% | +3.2% | −2.0% | +0.1% | +1.8% | −2.9% | +4.0% | −3.2% | +6.8% |
| 2020 | −4.2% | −10.1% | −18.5% | +12.2% | +3.0% | −0.4% | +2.1% | +3.5% | −3.0% | −0.9% | +16.0% | +4.3% |
| 2019 | — | — | — | — | — | — | +1.1% | −4.3% | +4.9% | +1.9% | +3.8% | +2.5% |
TQVAX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 12.31%
- 3-year Sharpe ratio: 1.07 (vs 4.5% risk-free rate)
- Best month: +8.08% (Apr 2026)
- Worst month: −7.18% (Dec 2024)
TQVAX Fund Flows
Monthly money in and out of T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund, from SEC Form N-PORT.
- 12-month net flow: $3.4M
- 12-month gross sales (incl. reinvestments): $47.7M
- Sales ÷ redemptions: 1.08×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $3.8M | $3.0M | $777K |
| May 2026 | $2.2M | $1.9M | $337K |
| Apr 2026 | $1.4M | $1.7M | −$305K |
| Mar 2026 | $1.4M | $2.8M | −$1.4M |
| Feb 2026 | $9.0M | $4.3M | $4.7M |
| Jan 2026 | $6.1M | $1.9M | $4.2M |
| Dec 2025 | $7.8M | $2.3M | $5.5M |
| Nov 2025 | $4.8M | $3.1M | $1.7M |
| Oct 2025 | $3.2M | $2.2M | $949K |
| Sep 2025 | $2.2M | $1.3M | $929K |
| Aug 2025 | $2.8M | $17.5M | −$14.7M |
| Jul 2025 | $3.0M | $2.3M | $749K |
TQVAX Assets Under Management
Net assets of T. Rowe Price Integrated U.S. Large-Cap Value Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $82.90M |
| 2026-03-31 | $72.69M |
| 2025-12-31 | $64.49M |
| 2025-09-30 | $57.17M |
| 2025-06-30 | $67.09M |
| 2025-03-31 | $65.38M |
| 2024-12-31 | $60.98M |
| 2024-09-30 | $40.33M |
| 2024-06-30 | $35.25M |
| 2024-03-31 | $35.06M |
| 2023-12-31 | $31.68M |
| 2023-09-30 | $28.98M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.